본문 바로가기 주메뉴 바로가기
  • HOME
  • R&D
  • Current Status of Development
  • Current Status of Development

Current Status of Development

Process of Development

  • 01 R&D
  • 02 Non-Clinical
  • 03 PHASE Ⅰ
  • 04 PHASE Ⅱ
  • 05 PHASE Ⅲ
  • 06 LAUNCH

Current Status of Development

Cancer Immunotherapy
As of July, 2021
2020년 02월 개발진행현황
Develop-
mental Stage
Indication R&D Non-
Clinical
Phase Ⅰ Phase Ⅱ Phase Ⅲ Launch Remarks
Complete Liver cancer (HCC) Phase IV observations
Brain tumor (Glioblas
toma)
New indications will be added
Pancreatic
cancer
    Phase II(IIT) clinical trial
Other six
cancer types
        Lung cancer,
Stomach cancer,
Renal cancer,
Prostate cancer,
Cervical cancer,
Melanoma(IIT)
In Progress Liver Can
cer
Early
·Mid
stage
    A clinical trial will be initiated (Phase II, IIT)
Liver
trans
plant
    A clinical trial will be initiated (Phase II, IIT)
Pancreatic
cancer
  A clinical trial was initiated (Phase III, SIT)
stomach cancer     A clinical trial was initiated (Phase II, IIT)
Breast
cancer
    A clinical trial was initiated (Phase II, IIT)
Ovarian
cancer
    A clinical trial was initiated (Phase II, IIT)

CAR-T Cell therapeutics
As of July, 2021
2018년 12월 개발진행현황
구분 R&D Non-Clinical Phase Ⅰ Phase Ⅱ Phase Ⅲ Launch 비고
CAR-T        

CAR-CIK
As of July, 2021
2018년 12월 개발진행현황
구분 R&D Non-Clinical Phase Ⅰ Phase Ⅱ Phase Ⅲ Launch 비고
Allogeneic          
Autologous